Geoff Nichol
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Geoff Nichol
Earlier roles on record: Board Member at Tempest Therapeutics, Inc. (TPST) until February 3, 2026 and Board Member at Tempest Therapeutics, Inc. (TPST) until November 19, 2025. Tempest Therapeutics, Inc. reported in an 8-K filed February 6, 2026 that Geoff Nichol resigned as Board, effective February 3, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed January 28, 2026 that Geoff Nichol was appointed Class I director, effective January 27, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed November 19, 2025 that Geoff Nichol resigned as board of directors of the Company.
“On February 3, 2026, immediately following the closing of the Asset Acquisition (the "Closing"), Geoff Nichol resigned from the Board, effective immediately.”
“The Company’s stockholders elected the person listed below as a Class I director, to serve until the Company’s 2028 Annual Meeting of Stockholders or until his successor is duly elected and qualified or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2026-01-27–2025-11-19
-
2019-01-01–2025-11-19
-
2019-01-01–2026-02-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.